发明名称 PHARMACEUTICAL COMPOSITION FOR IMMUNOREGULATION
摘要 PROBLEM TO BE SOLVED: To obtain the subject composition capable of lowering abnormally high CRP value and useful for treating cytokine-related diseases such as rheumatism, inflammation, allergy, atherosclerosis and hepatitis, by including a specific benzimidazole and others. SOLUTION: This pharmaceutical composition contains a benzimidazole of the formula (R is a 1-5C alkyl, hydroxyphenyl or methoxyphenyl) such as 2-(4-methoxyphenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6-pyridazinyl)-be nzimidazole, a 3H tautomer thereof, an optically active antipode thereof or a pharmaceutically acceptable acid addition salt thereof. It is preferable that the daily dose of this compound of the formula is 1.0-2.5 mg per adult.
申请公布号 JPH1192377(A) 申请公布日期 1999.04.06
申请号 JP19970253028 申请日期 1997.09.18
申请人 NIPPON BOEHRINGER INGELHEIM CO LTD 发明人 MATSUMORI AKIRA
分类号 C07D403/04;A61K31/50;A61P1/00;A61P1/16;A61P9/10;A61P13/02;A61P15/00;A61P29/00;A61P35/00;A61P37/02;A61P37/04;A61P37/06;A61P37/08;A61P43/00;(IPC1-7):A61K31/50 主分类号 C07D403/04
代理机构 代理人
主权项
地址